ASCO Seeks Principal Investigator for the TAPUR Study
Jason Westin, Lead of the Lymphoma and Myeloma Service Line at MD Anderson Cancer Center, shared a post on LinkedIn:
“The American Society of Clinical Oncology (ASCO) is now accepting applications for an experienced leader to serve as the next Principal Investigator for the groundbreaking Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study.
This volunteer position is a unique opportunity for a mid-to-senior level expert in academic medicine to shape the future of precision oncology research.
The ASCO-sponsored TAPUR is a first-of-its-kind non-randomized, open-label clinical trial that takes full advantage of modern research methods to address gaps in practical knowledge by adopting a tumor-agnostic approach to match real-world patients to drugs based on their tumor’s genomic profile. Learn more here.”
More posts featuring Jason Westin.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023